They observed that c-Met signaling was activated in metastatic cancer cells, which then enhanced the expression of G-CSF, granulocyte-macrophage-colony stimulating factor (GM-CSF), CXC motif chemokine ligand 1 (CXCL1) and CXCL2. Here, CSF2 is linked to metastatic malignant neoplasm.